Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 March 2022 : Clinical Research  

Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)

Ying Liao1BCE, Changhua Zhu ORCID logo2A*, Xiaoxia Song1CF, Jiugen Ruan2BCDF, Yao Ding2CF, Yuan Chen3BCDEF, Qiujuan Yang1F

DOI: 10.12659/MSM.934493

Med Sci Monit 2022; 28:e934493

Figure 2 Tissue samples were tested by capillary electrophoresis to confirmation MSI. The figure was edited using Microsoft PowerPoint 2010 (Microsoft, Redmond, WA, USA) from a screen shot from the Applied Biosystems (ABI 3500 DX) in Shanghai Tech Laboratory Co., Ltd. (Shanghai, China).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750